📋 Tender Overview
Contract awarded for Framework agreement for the supply of oncology medications for 48 months lot-0001, title: azacitidine 25mg/ml, description: according to the document "06 centralizer of estimated minimum and maximum values for medicines 48 months.xlsx.p7s" lot-0002, title: bosentan 125 mg, description: according to the document "06 centralizer of estimated minimum and maximum values for medicines 48 months.xlsx.p7s" lot-0003, title: deferasirox (reditens) 360 mg, description: according to the document "06 centralizer of estimated minimum and maximum values for medicines 48 months.xlsx.p7s" lot-0005, title: doxorubicin 2 mg/ml - 25 ml, description: according to the document "06 centralizer of estimated minimum and maximum values for medicines 48 months.xlsx.p7s" lot-0006, title: ectrenonacog alfa (alprolix) 1000ui, description: according to the document "06 centralizer of estimated minimum and maximum values for medicines 48 months.xlsx.p7s" lot-0007, title: ectrenonacog alfa (alprolix) 250ui, description: according to the document "06 centralizer of estimated minimum and maximum values for medicines 48 months.xlsx.p7s" lot-0008, title: ectrenonacog alfa (alprolix) 500ui, description: according to the document "06 centralizer of estimated minimum and maximum values for medicines 48 months.xlsx.p7s" lot-0010, title: recombinant factor viii 500ui with trehalose (octocog alfa) / advate, description: according to the document "06 centralizer of estimated minimum and maximum values for medicines 48 months.xlsx.p7s" lot-0014, title: mercaptopurine 50mg, description: according to the document "06 centralizer of estimated minimum and maximum values for medicines 48 months.xlsx.p7s" lot-0016, title: methotrexate 10mg/ml ser 1.5 ml, description: according to the document "06 centralizer of estimated minimum and maximum values for medicines 48 months.xlsx.p7s" estimated value excluding vat: 74472.00 ron.Framework agreement for the supply of oncology medications for 48 months
